Cancer Research AACR Membership  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by González-Suárez, E.
Right arrow Articles by Blasco, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by González-Suárez, E.
Right arrow Articles by Blasco, M. A.
[Cancer Research 63, 7047-7050, November 1, 2003]
© 2003 American Association for Cancer Research


Advances in Brief

Telomere Dysfunction Results in Enhanced Organismal Sensitivity to the Alkylating Agent N-Methyl-N-Nitrosourea1

Eva González-Suárez, Fermín A. Goytisolo, Juana M. Flores and María A. Blasco2

Department of Immunology and Oncology, National Center of Biotechnology [E. G. S., F. A. G., M. A. B.], and Animal Pathology II, Facultad de Veterinaria, Universidad Complutense de Madrid [J. M. F.], Madrid, Spain

Here, we use telomerase-deficient mice, Terc-/-, to study the impact of telomerase abrogation in response to treatment with the alkylating agent N-Methyl-N-Nitrosourea (MNU), a potent carcinogen in the mouse. Wild-type mice treated with MNU developed lymphomas and carcinomas. In contrast, similarly treated G5 Terc-/- mice with critically short telomeres did not develop tumors and died of acute toxicity to the small intestine. G2 Terc-/- mice, which have long telomeres, were less susceptible to MNU-induced tumors than wild-type mice, as well as less sensitive to MNU toxicity than G5 Terc-/- mice. The results indicate that short telomeres suppress tumor growth and that lack of telomerase retards tumor progression, even in the presence of long telomeres. Finally, G5 Terc-/- hypersensitivity to MNU supports the notion that short telomeres interfere with proper DNA damage repair.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
S. Ahmed, J. F. Passos, M. J. Birket, T. Beckmann, S. Brings, H. Peters, M. A. Birch-Machin, T. von Zglinicki, and G. Saretzki
Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress
J. Cell Sci., April 1, 2008; 121(7): 1046 - 1053.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Raval-Fernandes, V. A. Kickhoefer, C. Kitchen, and L. H. Rome
Increased Susceptibility of Vault Poly(ADP-Ribose) Polymerase-Deficient Mice to Carcinogen-Induced Tumorigenesis
Cancer Res., October 1, 2005; 65(19): 8846 - 8852.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
I. Flores, M. L. Cayuela, and M. A. Blasco
Effects of Telomerase and Telomere Length on Epidermal Stem Cell Behavior
Science, August 19, 2005; 309(5738): 1253 - 1256.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. L. Opresko, J. Fan, S. Danzy, D. M. Wilson III, and V. A. Bohr
Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2
Nucleic Acids Res., February 24, 2005; 33(4): 1230 - 1239.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.